טוען...
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
BACKGROUND: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer’s disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-inva...
שמור ב:
| הוצא לאור ב: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6521366/ https://ncbi.nlm.nih.gov/pubmed/31092279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0501-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|